2018
Prevalence and Risk Factors for Bariatric Surgery Readmissions
Berger ER, Huffman KM, Fraker T, Petrick AT, Brethauer SA, Hall BL, Ko CY, Morton JM. Prevalence and Risk Factors for Bariatric Surgery Readmissions. Annals Of Surgery 2018, 267: 122-131. PMID: 27849660, DOI: 10.1097/sla.0000000000002079.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultBariatric SurgeryConfidence IntervalsFemaleFollow-Up StudiesHumansIncidenceLaparoscopyMaleMiddle AgedObesity, MorbidPatient ReadmissionPostoperative ComplicationsPrevalencePrognosisQuality ImprovementRetrospective StudiesRisk AssessmentRisk FactorsTime FactorsUnited StatesYoung AdultConceptsLaparoscopic adjustable gastric bandingLaparoscopic sleeve gastrectomyPrimary bariatric surgeryBariatric surgeryReadmission ratesNutritional depletionPrimary laparoscopic adjustable gastric bandingAdjustable gastric bandingCurrent Procedural Terminology codesNational readmission ratesProcedural Terminology codesType of procedureRelated readmissionsAbdominal painGastric bandingGastric bypassLaparoscopic RouxSleeve gastrectomyAnastomotic leakPrimary outcomePrimary procedureRisk factorsCommon causeReadmissionLRYGB
2014
Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial
Ikramuddin S, Blackstone RP, Brancatisano A, Toouli J, Shah SN, Wolfe BM, Fujioka K, Maher JW, Swain J, Que FG, Morton JM, Leslie DB, Brancatisano R, Kow L, O’Rourke R, Deveney C, Takata M, Miller CJ, Knudson MB, Tweden KS, Shikora SA, Sarr MG, Billington CJ. Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial. JAMA 2014, 312: 915-922. PMID: 25182100, DOI: 10.1001/jama.2014.10540.Peer-Reviewed Original ResearchConceptsExcess weight lossNerve block groupPrimary safety objectiveWeight lossMorbid obesityAdverse eventsSham groupClinical trialsEfficacy objectiveMean percentage excess weight lossBlock groupPercentage excess weight lossSerious adverse event ratesSham-controlled clinical trialSham device groupVagal nerve blockadeWeight management educationSerious adverse eventsBariatric surgery resultsLong-term morbidityAdverse event ratesObesity-related conditionsNerve block therapyBody mass indexAbdominal pain